Journal article
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
Abstract
As new treatments continue to improve clinical outcomes in coronary artery disease (CAD) and heart failure, it is necessary to characterize the appropriate use of β-adrenergic receptor blockers (β-blockers) in the contemporary management of these conditions. This review examines the current evidence supporting β-blocker use in heart failure with preserved ejection fraction (HFpEF), heart failure with midrange ejection fraction (HFmEF), and …
Authors
Joseph P; Swedberg K; Leong DP; Yusuf S
Journal
Journal of the American College of Cardiology, Vol. 74, No. 5, pp. 672–682
Publisher
Elsevier
Publication Date
8 2019
DOI
10.1016/j.jacc.2019.04.067
ISSN
0735-1097